Literature DB >> 7275566

Treatment of severe Raynaud's phenomenon with prostaglandin E1.

J A Allen, M J O'Reilly.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7275566     DOI： 10.1007/BF02938232

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  4 in total

1.  Methods for the investigation of peripheral blood flow.

Authors:  A D GREENFIELD; R J WHITNEY; J F MOWBRAY
Journal:  Br Med Bull       Date:  1963-05       Impact factor: 4.291

2.  The effect of changes in local temperature on the blood flows of the normal hand, primary Raynaud's disease and primary acrocyanosis.

Authors:  J H PEACOCK
Journal:  Clin Sci       Date:  1960-11       Impact factor: 6.124

3.  Femoral-artery infusion of prostaglandin E 1 in severe peripheral vascular disease.

Authors:  L A Carlson; I Eriksson
Journal:  Lancet       Date:  1973-01-20       Impact factor: 79.321

4.  Intravenous prostaglandin E1 in severe peripheral vascular disease.

Authors:  L A Carlson; A G Olsson
Journal:  Lancet       Date:  1976-10-09       Impact factor: 79.321
  4 in total
  1 in total

1.  Inhibition of platelet aggregation by a new stable prostacyclin introduced in therapy of patients with progressive scleroderma.

Authors:  J Keller; A Kaltenecker; K T Schricker; B Neidhardt; O P Hornstein
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.